Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2003 Dec;74(12):1667–1673. doi: 10.1136/jnnp.74.12.1667

CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions

Y Dauvilliers 1, C Baumann 1, B Carlander 1, M Bischof 1, T Blatter 1, M Lecendreux 1, F Maly 1, A Besset 1, J Touchon 1, M Billiard 1, M Tafti 1, C Bassetti 1
PMCID: PMC1757412  PMID: 14638887

Abstract

Objective: To determine the role of CSF hypocretin-1 in narcolepsy with and without cataplexy, Kleine-Levin syndrome (KLS), idiopathic and other hypersomnias, and several neurological conditions.

Patients: 26 narcoleptic patients with cataplexy, 9 narcoleptic patients without cataplexy, 2 patients with abnormal REM-sleep-associated hypersomnia, 7 patients with idiopathic hypersomnia, 2 patients with post-traumatic hypersomnia, 4 patients with KLS, and 88 patients with other neurological disorders.

Results: 23 patients with narcolepsy-cataplexy had low CSF hypocretin-1 levels, while one patient had a normal hypocretin level (HLA-DQB1*0602 negative) and the other two had intermediate levels (familial forms). One narcoleptic patient without cataplexy had a low hypocretin level. One patient affected with post-traumatic hypersomnia had intermediate hypocretin levels. The KLS patients had normal hypocretin levels while asymptomatic, but one KLS patient (also affected with Prader-Willi syndrome) showed a twofold decrease in hypocretin levels during a symptomatic episode. Among the patients without hypersomnia, two patients with normal pressure hydrocephalus and one with unclear central vertigo had intermediate levels.

Conclusion: Low CSF hypocretin-1 is highly specific (99.1%) and sensitive (88.5%) for narcolepsy with cataplexy. Hypocretin ligand deficiency appears not to be the major cause for other hypersomnias, with a possible continuum in the pathophysiology of narcolepsy without cataplexy and idiopathic hypersomnia. However, partial hypocretin lesions without low CSF hypocretin-1 consequences cannot be definitely excluded in those disorders. The existence of normal hypocretin levels in narcoleptic patients and intermediate levels in other rare aetiologies needs further investigation, especially for KLS, to establish the functional significance of hypocretin neurotransmission alterations.

Full Text

The Full Text of this article is available as a PDF (255.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldrich M. S. Narcolepsy. Neurology. 1992 Jul;42(7 Suppl 6):34–43. [PubMed] [Google Scholar]
  2. Allen R. P., Mignot E., Ripley B., Nishino S., Earley C. J. Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome. Neurology. 2002 Aug 27;59(4):639–641. doi: 10.1212/wnl.59.4.639. [DOI] [PubMed] [Google Scholar]
  3. Bassetti C., Aldrich M. S. Idiopathic hypersomnia. A series of 42 patients. Brain. 1997 Aug;120(Pt 8):1423–1435. doi: 10.1093/brain/120.8.1423. [DOI] [PubMed] [Google Scholar]
  4. Bassetti Claudio, Gugger Matthias, Bischof Matthias, Mathis Johannes, Sturzenegger Christian, Werth Esther, Radanov Bogdan, Ripley Beth, Nishino Seiji, Mignot Emmanuel. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Sleep Med. 2003 Jan;4(1):7–12. doi: 10.1016/s1389-9457(02)00191-0. [DOI] [PubMed] [Google Scholar]
  5. Billiard M., Pasquié-Magnetto V., Heckman M., Carlander B., Besset A., Zachariev Z., Eliaou J. F., Malafosse A. Family studies in narcolepsy. Sleep. 1994 Dec;17(8 Suppl):S54–S59. doi: 10.1093/sleep/17.suppl_8.s54. [DOI] [PubMed] [Google Scholar]
  6. Chemelli R. M., Willie J. T., Sinton C. M., Elmquist J. K., Scammell T., Lee C., Richardson J. A., Williams S. C., Xiong Y., Kisanuki Y. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999 Aug 20;98(4):437–451. doi: 10.1016/s0092-8674(00)81973-x. [DOI] [PubMed] [Google Scholar]
  7. Chervin R. D., Aldrich M. S. Sleep onset REM periods during multiple sleep latency tests in patients evaluated for sleep apnea. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):426–431. doi: 10.1164/ajrccm.161.2.9905071. [DOI] [PubMed] [Google Scholar]
  8. Dalal M. A., Schuld A., Haack M., Uhr M., Geisler P., Eisensehr I., Noachtar S., Pollmächer T. Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology. 2001 Jun 26;56(12):1749–1751. doi: 10.1212/wnl.56.12.1749. [DOI] [PubMed] [Google Scholar]
  9. Dauvilliers Y., Mayer G., Lecendreux M., Neidhart E., Peraita-Adrados R., Sonka K., Billiard M., Tafti M. Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses. Neurology. 2002 Dec 10;59(11):1739–1745. doi: 10.1212/01.wnl.0000036605.89977.d0. [DOI] [PubMed] [Google Scholar]
  10. Ebrahim I. O., Sharief M. K., de Lacy S., Semra Y. K., Howard R. S., Kopelman M. D., Williams A. J. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia. J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):127–130. doi: 10.1136/jnnp.74.1.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gau S. F., Soong W. T., Liu H. M., Hou J. W., Tsai W. Y., Chiu Y. N., Yeh Y. C., Wang P. J., Wang T. R. Kleine-Levin syndrome in a boy with Prader-Willi syndrome. Sleep. 1996 Jan;19(1):13–17. [PubMed] [Google Scholar]
  12. Guilleminault C., Faull K. F., Miles L., van den Hoed J. Posttraumatic excessive daytime sleepiness: a review of 20 patients. Neurology. 1983 Dec;33(12):1584–1589. doi: 10.1212/wnl.33.12.1584. [DOI] [PubMed] [Google Scholar]
  13. Guilleminault C., Stoohs R., Quera-Salva M. A. Sleep-related obstructive and nonobstructive apneas and neurologic disorders. Neurology. 1992 Jul;42(7 Suppl 6):53–60. [PubMed] [Google Scholar]
  14. Guilleminault C., Yuen K. M., Gulevich M. G., Karadeniz D., Leger D., Philip P. Hypersomnia after head-neck trauma: a medicolegal dilemma. Neurology. 2000 Feb 8;54(3):653–659. doi: 10.1212/wnl.54.3.653. [DOI] [PubMed] [Google Scholar]
  15. Gunay-Aygun M., Schwartz S., Heeger S., O'Riordan M. A., Cassidy S. B. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics. 2001 Nov;108(5):E92–E92. doi: 10.1542/peds.108.5.e92. [DOI] [PubMed] [Google Scholar]
  16. Harley H. G., Brook J. D., Rundle S. A., Crow S., Reardon W., Buckler A. J., Harper P. S., Housman D. E., Shaw D. J. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature. 1992 Feb 6;355(6360):545–546. doi: 10.1038/355545a0. [DOI] [PubMed] [Google Scholar]
  17. Johns M. W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540–545. doi: 10.1093/sleep/14.6.540. [DOI] [PubMed] [Google Scholar]
  18. Kanbayashi Takashi, Inoue Yuichi, Chiba Shigeru, Aizawa Rika, Saito Yasushi, Tsukamoto Haruko, Fujii Yukiharu, Nishino Seiji, Shimizu Tetsuo. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res. 2002 Mar;11(1):91–93. doi: 10.1046/j.1365-2869.2002.00284.x. [DOI] [PubMed] [Google Scholar]
  19. Kanbayashi Takashi, Ishiguro Hideaki, Aizawa Rika, Saito Yasushi, Ogawa Yuriko, Abe Masahito, Hirota Kouichi, Nishino Seiji, Shimizu Tetsuo. Hypocretin-1 (orexin-A) concentrations in cerebrospinal fluid are low in patients with Guillain-Barré syndrome. Psychiatry Clin Neurosci. 2002 Jun;56(3):273–274. doi: 10.1046/j.1440-1819.2002.00974.x. [DOI] [PubMed] [Google Scholar]
  20. Katz Joshua D., Ropper Allan H. Familial Kleine-Levin syndrome: two siblings with unusually long hypersomnic spells. Arch Neurol. 2002 Dec;59(12):1959–1961. doi: 10.1001/archneur.59.12.1959. [DOI] [PubMed] [Google Scholar]
  21. Krahn Lois E., Pankratz V. Shane, Oliver Lawrence, Boeve Bradley F., Silber Michael H. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status. Sleep. 2002 Nov 1;25(7):733–736. doi: 10.1093/sleep/25.7.733. [DOI] [PubMed] [Google Scholar]
  22. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., de Jong P. J., Nishino S., Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 1999 Aug 6;98(3):365–376. doi: 10.1016/s0092-8674(00)81965-0. [DOI] [PubMed] [Google Scholar]
  23. Manni R., Politini L., Nobili L., Ferrillo F., Livieri C., Veneselli E., Biancheri R., Martinetti M., Tartara A. Hypersomnia in the Prader Willi syndrome: clinical-electrophysiological features and underlying factors. Clin Neurophysiol. 2001 May;112(5):800–805. doi: 10.1016/s1388-2457(01)00483-7. [DOI] [PubMed] [Google Scholar]
  24. Mignot E. Genetic and familial aspects of narcolepsy. Neurology. 1998 Feb;50(2 Suppl 1):S16–S22. doi: 10.1212/wnl.50.2_suppl_1.s16. [DOI] [PubMed] [Google Scholar]
  25. Mignot Emmanuel, Lammers Gert Jan, Ripley Beth, Okun Michele, Nevsimalova Sonia, Overeem Sebastiaan, Vankova Jitka, Black Jed, Harsh John, Bassetti Claudio. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol. 2002 Oct;59(10):1553–1562. doi: 10.1001/archneur.59.10.1553. [DOI] [PubMed] [Google Scholar]
  26. Nishino S., Ripley B., Overeem S., Lammers G. J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000 Jan 1;355(9197):39–40. doi: 10.1016/S0140-6736(99)05582-8. [DOI] [PubMed] [Google Scholar]
  27. Nishino S., Ripley B., Overeem S., Nevsimalova S., Lammers G. J., Vankova J., Okun M., Rogers W., Brooks S., Mignot E. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol. 2001 Sep;50(3):381–388. doi: 10.1002/ana.1130. [DOI] [PubMed] [Google Scholar]
  28. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., Nevsimalova S., Aldrich M., Reynolds D., Albin R. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000 Sep;6(9):991–997. doi: 10.1038/79690. [DOI] [PubMed] [Google Scholar]
  29. Ripley B., Overeem S., Fujiki N., Nevsimalova S., Uchino M., Yesavage J., Di Monte D., Dohi K., Melberg A., Lammers G. J. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology. 2001 Dec 26;57(12):2253–2258. doi: 10.1212/wnl.57.12.2253. [DOI] [PubMed] [Google Scholar]
  30. Thannickal T. C., Moore R. Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., Siegel J. M. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000 Sep;27(3):469–474. doi: 10.1016/s0896-6273(00)00058-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Willie J. T., Chemelli R. M., Sinton C. M., Yanagisawa M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci. 2001;24:429–458. doi: 10.1146/annurev.neuro.24.1.429. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES